Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Cerilliant
Farmers Insurance
Chinese Patent Office
Healthtrust
Boehringer Ingelheim
AstraZeneca
Accenture

Generated: September 21, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DOPAMINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Dopamine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated National Institute on Drug Abuse (NIDA) Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated VA Connecticut Healthcare System Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated Yale University Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Dopamine Hydrochloride

Condition Name

Condition Name for Dopamine Hydrochloride
Intervention Trials
Schizophrenia 87
Parkinson's Disease 63
Parkinson Disease 45
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dopamine Hydrochloride
Intervention Trials
Parkinson Disease 129
Schizophrenia 92
Disease 66
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dopamine Hydrochloride

Trials by Country

Trials by Country for Dopamine Hydrochloride
Location Trials
United States 737
Canada 62
Germany 54
France 47
United Kingdom 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dopamine Hydrochloride
Location Trials
New York 65
California 57
Maryland 56
Connecticut 44
Massachusetts 44
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dopamine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dopamine Hydrochloride
Clinical Trial Phase Trials
Phase 4 150
Phase 3 103
Phase 2/Phase 3 28
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dopamine Hydrochloride
Clinical Trial Phase Trials
Completed 405
Recruiting 117
Unknown status 59
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dopamine Hydrochloride

Sponsor Name

Sponsor Name for Dopamine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 55
National Institute of Mental Health (NIMH) 34
Yale University 25
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dopamine Hydrochloride
Sponsor Trials
Other 860
Industry 177
NIH 150
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Fuji
Cerilliant
Johnson and Johnson
Moodys
Daiichi Sankyo
Citi
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.